Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Sign on to:
My Account
Receive email
updates
Edit Profile
CMU Intellectual Repository
Browsing by Author Anchalee Avihingsanon
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 6 to 25 of 26
< previous
next >
Issue Date
Title
Author(s)
4-May-2019
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials
Yeon Sook Kim
;
Shinichi Oka
;
Ploenchan Chetchotisakd
;
Amanda Clarke
;
Khuanchai Supparatpinyo
;
Anchalee Avihingsanon
;
Winai Ratanasuwan
;
Sasisopin Kiertiburanakul
;
Kiat Ruxrungtham
;
Sang Youn Yang
;
Susan Guo
;
Ya Pei Liu
;
Moupali Das
;
Do Tran
;
Damian McColl
;
Roberto Corales
;
Chris Nguyen
;
David Piontkowsky
1-Jun-2021
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
Isabelle Andrieux-Meyer
;
Soek Siam Tan
;
Sombat Thanprasertsuk
;
Nicolas Salvadori
;
Caroline Menétrey
;
François Simon
;
Tim R. Cressey
;
Hajjah Rosaida Hj Mohd Said
;
Muhammad Radzi Abu Hassan
;
Haniza Omar
;
Hoi Poh Tee
;
Wah Kheong Chan
;
Suresh Kumar
;
Satawat Thongsawat
;
Kanawee Thetket
;
Anchalee Avihingsanon
;
Suparat Khemnark
;
Sabine Yerly
;
Nicole Ngo-Giang-Huong
;
Sasikala Siva
;
Alistair Swanson
;
Vishal Goyal
;
Francois Bompart
;
Bernard Pécoul
;
Shahnaz Murad
1-Jan-2022
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials
Anchalee Avihingsanon
;
Ploenchan Chetchotisakd
;
Sasisopin Kiertiburanakul
;
Winai Ratanasuwan
;
Krittaecho Siripassorn
;
Khuanchai Supparatpinyo
;
Hal Martin
;
Hui Wang
;
Tin Hung Wong
;
Hsiu Yin Wang
1-Apr-2015
Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy
Stephen J. Kerr
;
Baralee Punyawudho
;
Narukjaporn Thammajaruk
;
Angela Colbers
;
Prachya Chaiyahong
;
Supalak Phonphithak
;
Vorapot Sapsirisavat
;
Kiat Ruxrungtham
;
David M. Burger
;
Anchalee Avihingsanon
1-Jun-2021
Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation
Carolyn A. Luscombe
;
Anchalee Avihingsanon
;
Khuanchai Supparatpinyo
;
Sivaporn Gatechompol
;
Win Min Han
;
Gary D. Ewart
;
Audrey S. Thomson
;
Michelle Miller
;
Stephen Becker
;
Robert L. Murphy
1-Jun-2015
Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients
Kanokrat Rungtivasuwan
;
Anchalee Avihingsanon
;
Narukjaporn Thammajaruk
;
Siwaporn Mitruk
;
David M. Burger
;
Kiat Ruxrungtham
;
Baralee Punyawudho
;
Thitima Pengsuparp
24-May-2019
Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients
Noppaket Singkham
;
Anchalee Avihingsanon
;
Narukjaporn Thammajaruk
;
Kiat Ruxrungtham
;
Torsak Bunupuradah
;
Sasisopin Kiertiburanakul
;
Ploenchan Chetchotisakd
;
David M. Burger
;
Sean Emery
;
Baralee Punyawudho
1-Apr-2022
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
Sunil S. Solomon
;
Sandra Wagner-Cardoso
;
Laura Smeaton
;
Leonard A. Sowah
;
Chanelle Wimbish
;
Gregory Robbins
;
Irena Brates
;
Christine Scello
;
Annie Son
;
Anchalee Avihingsanon
;
Benjamin Linas
;
Donald Anthony
;
Estevão Portela Nunes
;
Dimas A. Kliemann
;
Khuanchai Supparatpinyo
;
Cissy Kityo
;
Pablo Tebas
;
Jaclyn Ann Bennet
;
Jorge Santana-Bagur
;
Constance A. Benson
;
Marije Van Schalkwyk
;
Nelson Cheinquer
;
Susanna Naggie
;
David Wyles
;
Mark Sulkowski
1-Jan-2022
Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients
Noppaket Singkham
;
Anchalee Avihingsanon
;
Richard C. Brundage
;
Angela K. Birnbaum
;
Narukjaporn Thammajaruk
;
Kiat Ruxrungtham
;
Torsak Bunupuradah
;
Sasisopin Kiertiburanakul
;
Ploenchan Chetchotisakd
;
Baralee Punyawudho
1-Nov-2017
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
Kanokrat Rungtivasuwan
;
Anchalee Avihingsanon
;
Narukjaporn Thammajaruk
;
Siwaporn Mitruk
;
David M. Burger
;
Kiat Ruxrungtham
;
Chonlaphat Sukasem
;
Baralee Punyawudho
1-Jan-2015
Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
Tim R. Cressey
;
Anchalee Avihingsanon
;
Guttiga Halue
;
Prattana Leenasirimakul
;
Pra Ornsuda Sukrakanchana
;
Yardpiroon Tawon
;
Nirattiya Jaisieng
;
Gonzague Jourdain
;
Anthony T. Podany
;
Courtney V. Fletcher
;
Virat Klinbuayaem
;
Chureeratana Bowonwatanuwong
1-Mar-2017
Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
Baralee Punyawudho
;
Narukjaporn Thammajaruk
;
Kiat Ruxrungtham
;
Anchalee Avihingsanon
1-Nov-2015
Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients
Baralee Punyawudho
;
Narukjaporn Thammajaruk
;
Parawee Thongpeang
;
Gail Matthews
;
Sharon R. Lewin
;
David Burger
;
Kiat Ruxrungtham
;
Anchalee Avihingsanon
Dec-2022
Population pharmacokinetics-pharmacogenetics of efavirenz and population pharmacokinetics of lopinavir/ritonavir in Thai HIV-infected patients
Baralee Punyawudho
;
Anchalee Avihingsanon
;
Weerawat Manosuthi
;
Piyawat Chaivichacharn
1-Jun-2022
Recent Trends in Adult and Pediatric Antiretroviral Therapy Monitoring and Failure
David C. Boettiger
;
Vu Thien An
;
Nagalingeswaran Kumarasamy
;
Iskandar Azwa
;
Tavitiya Sudjaritruk
;
Khanh Huu Truong
;
Anchalee Avihingsanon
;
Jeremy Ross
;
Azar Kariminia
1-Aug-2016
Renal dysfunction during tenofovir use in a regional cohort of HIV-infected individuals in the Asia-Pacific
Junko Tanuma
;
Awachana Jiamsakul
;
Abhimanyu Makane
;
Anchalee Avihingsanon
;
Oon Tek Ng
;
Sasisopin Kiertiburanakul
;
Romanee Chaiwarith
;
Nagalingeswaran Kumarasamy
;
Kinh Van Nguyen
;
Thuy Thanh Pham
;
Man Po Lee
;
Rossana Ditangco
;
Tuti Parwati Merati
;
Jun Yong Choi
;
Wing Wai Wong
;
Adeeba Kamarulzaman
;
Evy Yunihastuti
;
Benedict Lh Sim
;
Winai Ratanasuwan
;
Pacharee Kantipong
;
Fujie Zhang
;
Mahiran Mustafa
;
Vonthanak Saphonn
;
Sanjay Pujari
;
Annette H. Sohn
;
C. V. Mean
;
V. Saphonn
;
K. Vohith
;
F. J. Zhang
;
H. X. Zhao
;
N. Han
;
P. C.K. Li
;
W. Lam
;
Y. T. Chan
;
K. H. Wong
;
S. Saghayam
;
C. Ezhilarasi
;
K. Joshi
;
D. N. Wirawan
;
F. Yuliana
;
D. Imran
;
A. Widhani
;
S. Oka
;
T. Nishijima
;
S. Na
;
J. M. Kim
;
Y. M. Gani
;
R. David
;
S. F.Syed Omar
;
S. Ponnampalavanar
;
I. Azwa
;
N. Huda
;
L. Y. Ong
;
E. Uy
;
R. Bantique
;
W. W. Ku
;
P. C. Wu
;
P. L. Lim
;
L. S. Lee
;
P. S. Ohnmar
;
P. Phanuphak
;
K. Ruxrungtham
;
P. Chusut
;
S. Sirivichayakul
;
S. Sungkanuparph
;
L. Chumla
;
N. Sanmeema
;
R. Chaiwarith
;
T. Sirisanthana
;
W. Kotarathititum
;
J. Praparattanapan
;
P. Kantipong
;
P. Kambua
;
R. Sriondee
;
V. H. Bui
;
T. T. Cao
;
D. D. Cuong
;
H. L. Ha
;
N. Durier
;
B. Petersen
;
T. Singtoroj
;
D. A. Cooper
;
M. G. Law
;
D. C. Boettiger
1-Jun-2020
Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis
David C. Boettiger
;
Anthony T. Newall
;
Pairoj Chattranukulchai
;
Romanee Chaiwarith
;
Suwimon Khusuwan
;
Anchalee Avihingsanon
;
Andrew Phillips
;
Eran Bendavid
;
Matthew G. Law
;
James G. Kahn
;
Jeremy Ross
;
Sergio Bautista-Arredondo
;
Sasisopin Kiertiburanakul
1-Nov-2019
Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial
Cissy Kityo
;
Debbie Hagins
;
Ellen Koenig
;
Anchalee Avihingsanon
;
Ploenchan Chetchotisakd
;
Khuanchai Supparatpinyo
;
Natalya Gankina
;
Vadim Pokrovsky
;
Evgeny Voronin
;
Jeffrey L. Stephens
;
Edwin Dejesus
;
Hui Wang
;
Rima K. Acosta
;
Huyen Cao
;
Erin Quirk
;
Hal Martin
;
Tariro Makadzange
1-Sep-2019
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
Beatriz Grinsztejn
;
Michael D. Hughes
;
Justin Ritz
;
Robert Salata
;
Peter Mugyenyi
;
Evelyn Hogg
;
Linda Wieclaw
;
Robert Gross
;
Catherine Godfrey
;
Sandra W. Cardoso
;
Aggrey Bukuru
;
Mumbi Makanga
;
Sharlaa Faesen
;
Vidya Mave
;
Beatrice Wangari Ndege
;
Sandy Nerette Fontain
;
Wadzanai Samaneka
;
Rode Secours
;
Marije van Schalkwyk
;
Rosie Mngqibisa
;
Lerato Mohapi
;
Javier Valencia
;
Patcharaphan Sugandhavesa
;
Esmelda Montalban
;
Anchalee Avihingsanon
;
Breno R. Santos
;
Nagalingeswaran Kumarasamy
;
Cecilia Kanyama
;
Robert T. Schooley
;
John W. Mellors
;
Carole L. Wallis
;
Ann C. Collier
;
B. Grinsztejn
;
P. N. Mugyenyi
;
A. Collier
;
R. Salata
;
C. Godfrey
;
E. Hogg
;
M. Hughes
;
J. Ritz
;
L. Wieclaw
;
T. Sise
;
J. W. Mellors
;
C. Wallis
;
C. V. Fletcher
;
M. Gandhi
;
R. Gross
;
R. T. Schooley
;
R. Walensky
;
M. van Schalkwyk
;
S. Faesen
;
R. Mngqibisa
;
J. Valencia
;
E. Montalban
;
N. Kumarasamy
;
C. Kanyama
;
S. W. Cardoso
;
B. R. Santos
;
B. Mansfield
;
H. Mugerwa
;
B. W. Ndege
;
R. Secours
;
W. Samaneka
;
D. Kadam
;
V. Mave
;
M. Makanga
;
S. N. Fontain
;
P. Sugandhavesa
;
A. Avihingsanon
;
L. Nakibuuka
;
H. Nassolo
;
P. Anthony
;
V. Kulkarni
;
M. Nsubuga
;
J. van Wyk
;
J. Rooney
;
Y. van Delft
;
R. Leavitt
;
R. Luk
;
A. Benns
;
L. Hovind
;
A. Shahkolahi
1-Jun-2022
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial
Anchalee Avihingsanon
;
Michael D. Hughes
;
Robert Salata
;
Catherine Godfrey
;
Caitlyn McCarthy
;
Peter Mugyenyi
;
Evelyn Hogg
;
Robert Gross
;
Sandra W. Cardoso
;
Aggrey Bukuru
;
Mumbi Makanga
;
Sharlaa Badal-aesen
;
Vidya Mave
;
Beatrice Wangari Ndege
;
Sandy Nerette Fontain
;
Wadzanai Samaneka
;
Rode Secours
;
Marije Van Schalkwyk
;
Rosie Mngqibisa
;
Lerato Mohapi
;
Javier Valencia
;
Patcharaphan Sugandhavesa
;
Esmelda Montalban
;
Cornelius Munyanga
;
Maganizo Chagomerana
;
Breno R. Santos
;
Nagalingeswaran Kumarasamy
;
Cecilia Kanyama
;
Robert T. Schooley
;
John W. Mellors
;
Carole L. Wallis
;
Ann C. Collier
;
Beatriz Grinsztejn